1143 related articles for article (PubMed ID: 21871784)
1. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
[TBL] [Abstract][Full Text] [Related]
2. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
3. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
[TBL] [Abstract][Full Text] [Related]
4. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
5. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
[TBL] [Abstract][Full Text] [Related]
6. Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit.
Tsakris A; Ikonomidis A; Poulou A; Spanakis N; Vrizas D; Diomidous M; Pournaras S; Markou F
Clin Microbiol Infect; 2008 Jun; 14(6):588-94. PubMed ID: 18397334
[TBL] [Abstract][Full Text] [Related]
7. Outbreak of imipenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex harboring different carbapenemase gene-associated genetic structures in an intensive care unit.
Lee YT; Fung CP; Wang FD; Chen CP; Chen TL; Cho WL
J Microbiol Immunol Infect; 2012 Feb; 45(1):43-51. PubMed ID: 22169123
[TBL] [Abstract][Full Text] [Related]
8. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
Héritier C; Dubouix A; Poirel L; Marty N; Nordmann P
J Antimicrob Chemother; 2005 Jan; 55(1):115-8. PubMed ID: 15590718
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
[TBL] [Abstract][Full Text] [Related]
10. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
11. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
Manageiro V; Jones-Dias D; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2012 Nov; 40(5):398-403. PubMed ID: 22890192
[TBL] [Abstract][Full Text] [Related]
12. Detection of OXA-type carbapenemases and integrons among carbapenem-resistant Acinetobactor baumannii in a teaching hospital in China.
Hu Q; Hu Z; Li J; Tian B; Xu H; Li J
J Basic Microbiol; 2011 Oct; 51(5):467-72. PubMed ID: 21656808
[TBL] [Abstract][Full Text] [Related]
13. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.
Ruiz M; Marti S; Fernandez-Cuenca F; Pascual A; Vila J
Clin Microbiol Infect; 2007 Dec; 13(12):1192-8. PubMed ID: 17850347
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Wang H; Guo P; Sun H; Wang H; Yang Q; Chen M; Xu Y; Zhu Y
Antimicrob Agents Chemother; 2007 Nov; 51(11):4022-8. PubMed ID: 17846127
[TBL] [Abstract][Full Text] [Related]
16. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of bla(OXA)-23 in oligoclonal carbapenem-resistant Acinetobacter baumannii from Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Thapa B; Tribuddharat C; Srifuengfung S; Dhiraputra C
Southeast Asian J Trop Med Public Health; 2010 May; 41(3):625-35. PubMed ID: 20578551
[TBL] [Abstract][Full Text] [Related]
18. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
[TBL] [Abstract][Full Text] [Related]
19. Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene status.
Esterly JS; Qi C; Malczynski M; Scheetz MH
Pharmacotherapy; 2010 Apr; 30(4):354-60. PubMed ID: 20334455
[TBL] [Abstract][Full Text] [Related]
20. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
